Joshua M. Eizen - Chief Operating Officer and Chief Legal Officer at AN2 Therapeutics, Inc.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Joshua M. Eizen in AN2 Therapeutics, Inc.

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-33,625
Avg price
$1.83
Total value
-$61,691

Net

Past year
Shares
-33,625
Share %
-100%
Total value
-$61,691

Reported holdings for Joshua M. Eizen in AN2 Therapeutics, Inc.

Form 4 holding Chief Operating Officer and Chief Legal Officer

AN2 Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
19 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for Joshua M. Eizen in AN2 Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .